1. Home
  2. |Insights
  3. |Glen McGorty and Rosa Morales Named as Crain’s New York Business 2024 Notable Leaders in Law

Glen McGorty and Rosa Morales Named as Crain’s New York Business 2024 Notable Leaders in Law

Firm News | 3 min read | 12.12.24

New York – December 12, 2024: Glen McGorty, managing partner of Crowell & Moring’s New York office and member of the management board, and Rosa Morales, counsel in the firm’s Antitrust and Competition Group, have been named to Crain’s New York Business’ 2024 list of Notable Leaders in Accounting, Consulting, & Law. As reported by Crain’s, the 101 honorees on the list possess the financial, strategic, and legal experience “to drive significant commercial activity in the region, shaping New York City’s business landscape and fostering enterprise growth.”

McGorty is a member of the firm’s White Collar & Regulatory Enforcement Group and the Financial Services Practice, and serves as co-chair of its Litigation and Trial Department. He is an experienced trial lawyer who served almost 15 years as a federal prosecutor in the U.S. Attorney's Office for the Southern District of New York and the U.S. Department of Justice in Washington, D.C. McGorty represents corporate entities and individuals in federal and state criminal and regulatory matters, and in investigations conducted by grand juries, congressional committees, independent and special counsel, and international, federal, and state law enforcement and regulatory agencies. He also leads the firm’s monitorship practice and has served as court appointed monitor of the New York City District Council of Carpenters for the past decade, and, since 2021, has served on the monitor team for the United Autoworkers of America, overseeing the union’s first ever union-wide national mail-in ballot officer election.

Morales has over a decade of experience as an antitrust attorney. She focuses on on high-stakes litigation and compliance matters for industry-leading clients. Morales represents Fortune 500 companies, boards of directors, and senior executives in business-critical antitrust matters, including complex private antitrust litigation, class action defense, multidistrict litigation, and government enforcement actions spanning multiple sectors, including healthcare, higher education, technology, media, and financial services. Her deep antitrust expertise and practical understanding of her clients’ business objectives allows her to deliver strategic litigation management in bet-the-company matters, risk-informed compliance guidance, industry-specific regulatory insights, and practical, business-oriented solutions. As trusted advisor, Morales also provides strategic guidance to clients through tailored compliance counseling, risk assessment and mitigation strategies, comprehensive compliance programs, and proactive risk management solutions. 

Click here to read McGorty’s profile in Crain’s, and click here to read Morales’ profile.

About Crowell & Moring LLP

Crowell & Moring is an international law firm with operations in the United States, Europe, MENA, and Asia. Drawing on significant government, business, industry and legal experience, the firm helps clients capitalize on opportunities and provides creative solutions to complex litigation and arbitration, regulatory and policy, and corporate and transactional issues. The firm is consistently recognized for its commitment to pro bono service as well as its programs and initiatives to advance diversity, equity, and inclusion.  

Media Contact:
Email: prteam@crowell.com

Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....